BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. The company was founded in 2007 and is based in Yongin-si, South Korea.
Metrics to compare | 199730 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship199730PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.0x | −7.3x | −0.5x | |
PEG Ratio | 0.03 | 0.03 | 0.00 | |
Price/Book | 1.1x | 1.6x | 2.6x | |
Price / LTM Sales | 1.0x | 3.5x | 3.3x | |
Upside (Analyst Target) | - | 20.3% | 48.1% | |
Fair Value Upside | Unlock | 0.3% | 7.7% | Unlock |